Langley Steinert sold $2.1M of CARG
Executive Chair at CarGurus, Inc.. 68,793 shares at an average of $30.20, traded Mar 18, 2025, filed Mar 20, 2025.
Score components
- +20RoleChair
- +25Trade size$2.1M at market
- 0Share of holdings soldSold 5.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.9%, 3m +6.3%, 6m +25.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-010162, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -20,004 | $30.29 | $606k | 1,159,683 | Mar 20, 2025 |
| Mar 18, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -636 | $30.94 | $20k | 1,159,047 | Mar 20, 2025 |
| Mar 18, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -2,221 | $30.29 | $67k | 72,540 | Mar 20, 2025 |
| Mar 18, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -70 | $30.94 | $2,166 | 72,470 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -19,694 | $30.13 | $593k | 1,139,353 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -946 | $30.81 | $29k | 1,138,407 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -2,187 | $30.13 | $66k | 70,283 | Mar 20, 2025 |
| Mar 19, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -104 | $30.81 | $3,204 | 70,179 | Mar 20, 2025 |
| Mar 20, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -19,706 | $30.12 | $594k | 1,118,701 | Mar 20, 2025 |
| Mar 20, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -934 | $30.53 | $29k | 1,117,767 | Mar 20, 2025 |
| Mar 20, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -2,188 | $30.12 | $66k | 67,991 | Mar 20, 2025 |
| Mar 20, 2025 | SOpen-market sale Class A Common Stockindirect: See Footnote10b5-1 | -103 | $30.53 | $3,145 | 67,888 | Mar 20, 2025 |
Related signals
Other insiders at CarGurus, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | CarGurus, Inc. | Ismail Elshareef Chief Product Officer | $79k 2,673 shares | -2% | |
| 20Weak | CarGurus, Inc. | Matthew Todd Quinn Chief Technology Officer | $113k 3,824 shares | -2% | |
| 22Weak | CarGurus, Inc. | Dafna Sarnoff Chief Marketing Officer | $214k 7,234 shares | -7% | |
| 15Weak | CarGurus, Inc. | Samuel Zales COO and President | $346k 10,000 shares | -2% | |
| 23Weak | CarGurus, Inc. | Samuel Zales COO and President | $365k 10,000 shares | -2% | |
| 25Weak | CarGurus, Inc. | Ismail Elshareef Chief Product Officer | $340k 8,957 shares | -6% | |
| 65Notable | CarGurus, Inc. | Greg M Schwartz director | $361k 10,000 shares | -53% | |
| 35Weak | CarGurus, Inc. | Dafna Sarnoff Chief Marketing Officer | $635k 17,151 shares | -14% | |
| 26Weak | CarGurus, Inc. | Jason Trevisan Chief Executive Officer | $45k 1,100 shares | -0% | |
| 23Weak | CarGurus, Inc. | Javier Esquivel Zamora General Counsel and Secretary | $230k 6,205 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.